학술논문
Diabetic ketoacidosis inducing myocardial infarction secondary to treatment with dapagliflozin: a case report.
Document Type
Article
Author
Source
Subject
*DAPAGLIFLOZIN
*SODIUM-glucose cotransporters
*BLOOD sugar measurement
*THERAPEUTICS
MYOCARDIAL infarction diagnosis
*
*
*
Language
ISSN
2050-0904
Abstract
Key Clinical Message Sodium-glucose cotransporter 2 ( SGLT2) inhibitors are able to provoke diabetic ketoacidosis ( DKA) with absence or low levels of ketone bodies in urine and slightly elevated blood glucose levels, which could delay the diagnosis; however, the presence of high urine output, due to the excretion of glucose, can help to identify the true cause. [ABSTRACT FROM AUTHOR]